Please login to the form below

Not currently logged in
Email:
Password:

Venclyxto

This page shows the latest Venclyxto news and features for those working in and with pharma, biotech and healthcare.

Roche and AbbVie prepare to move Venclexta into first-line CLL

Roche and AbbVie prepare to move Venclexta into first-line CLL

AbbVie and Roche’s BCL-2 inhibitor Venclexta/Venclyxto has already been making waves in second-line chronic lymphocytic leukaemia (CLL) but is now poised to move into front-line therapy, ... CLL14 is the first study to show superior progression-free

Latest news

More from news
Approximately 4 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
Peoples Award
Quality in Care Diabetes 2018: the best in innovative diabetes care
Awards highlight new evidence-based approaches to improving care...

Infographics